These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 234201)

  • 1. Solubility fo fibrin clots in monochloroacetic acid. A reflection of serum pepsinogen levels.
    Ikemori R; Gruhl M; Shrivastava S; Shanberge JN
    Am J Clin Pathol; 1975 Jan; 63(1):49-56. PubMed ID: 234201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests.
    Duncan EM; Dale BJ; Lloyd JV
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):340-8. PubMed ID: 24440916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
    Ragaz S; Kemp G; Furlan M; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique "mini" pepsinogen isolated from bullfrog esophageal glands.
    Shugerman RP; Hirschowitz BI; Bhown AS; Schrohenloher RE; Spenney JG
    J Biol Chem; 1982 Jan; 257(2):795-8. PubMed ID: 6976347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congenital deficiency of fibrin stabilizing factor [factor XIII)].
    Blanckaert D; Oueidat I; Chelala J; Loeuille GA; Delepoulle F
    Pediatrie; 1993; 48(6):451-3. PubMed ID: 8247644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII.
    Kitchens CS; Newcomb TF
    Medicine (Baltimore); 1979 Nov; 58(6):413-29. PubMed ID: 514066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pepsinogen forms in cattle, sheep and goats.
    Mostofa M; McKellar QA; Eckersall PD
    Res Vet Sci; 1990 Jan; 48(1):33-7. PubMed ID: 2300712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of Japanese monkey prostate acid protease zymogen and its identification as a pepsinogen C-like zymogen.
    Moriyama A; Kageyama T; Takahashi K; Sasaki M
    J Biochem; 1985 Nov; 98(5):1255-61. PubMed ID: 3936848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of human gastric proteases by immunoadsorbents. Pepsinogen I group.
    Zöller M; Matzku S; Rapp W
    Biochim Biophys Acta; 1976 Apr; 427(2):708-18. PubMed ID: 817742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of stabilized fibrin to urea dispersion by undiluted plasma and serum.
    de Cataldo F; Baudo F
    Acta Haematol; 1977; 58(2):79-83. PubMed ID: 409022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ostrich pepsinogens I and II: purification, activation and chemical and immunochemical characterization of the enzymes from the proventriculus.
    Pletschke BI; Naudé RJ; Oelofsen W; Muramoto K; Yamauchi F
    Int J Biochem Cell Biol; 1995 Jun; 27(6):613-24. PubMed ID: 7671140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for bovine pepsinogen purification. Preparation of a specific antibody.
    Gomes MA; Lima Wdos S; Pesquero JL
    J Immunoassay; 1994 May; 15(2):157-70. PubMed ID: 8040350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the relationship between factor XIII activity and fibrin clot solubility test by urea and monochloroacetic acid (author's transl)].
    Ukita M; Mikami K; Kitahara T; Kato M; Kani T; Yano Y
    Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):963-8. PubMed ID: 610332
    [No Abstract]   [Full Text] [Related]  

  • 15. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple forms of bovine pepsinogen: isolation and identification in serum from calves with ostertagiasis.
    Eckersall PD; Macaskill J; McKellar QA; Bryce KL
    Res Vet Sci; 1987 Nov; 43(3):279-83. PubMed ID: 3444973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seminal pepsinogen C is not identical with, but is very similar to gastric pepsinogen C.
    Szecsi PB; Koch C; Foltmann B
    FEBS Lett; 1988 Sep; 238(1):101-4. PubMed ID: 3169243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of human gastric proteases by immunoadsorbents: pepsinogen II-group.
    Matzku S; Rapp W
    Biochim Biophys Acta; 1976 Sep; 446(1):30-40. PubMed ID: 823970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an in vitro fibrin clot model to evaluate fibrinolytic agents for wound care application.
    Viennet C; Laurensou C; Goydadin AC; Faivre B; Muret P; Humbert P
    J Wound Care; 2014 Feb; 23(2):66-7, 70, 72. PubMed ID: 24526082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC; Lockhart MS; Taylor FB
    J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.